Maven Bio
YC S23Boston, US · Founded 2023 · 10 employees · 1 known investors
Maven Bio provides software for biotech investment firms to accelerate due diligence and thesis development, automating screening, competitive analysis, and clinical data review to compress research timelines from days to hours.
AI & Machine LearningBiotechData & InfrastructureEnterprise SoftwareFintechSaaSGenerative AIHealthcareEnterpriseHealthcare ITin /mavenbio@AMurthy100
Founders & leadership· Y Combinator alumni (S23)
Michael BradyinFounder
Investors · 1
In the news
- Maven Bio - 2026 Company Profile & Competitors - Tracxntracxn.com · 2025
- Maven Bio Secures $3.1M Seed Round to Revolutionize AI-Driven BioPharma Insights | SignalBasetrysignalbase.com · 2025
- Maven Bio Funding | Complete Analysis | Extruct AIextruct.ai · 2023